ACS Medicinal Chemistry Letters

3.1k papers and 59.8k indexed citations i.

About

The 3.1k papers published in ACS Medicinal Chemistry Letters in the last decades have received a total of 59.8k indexed citations. Papers published in ACS Medicinal Chemistry Letters usually cover Molecular Biology (1.9k papers), Organic Chemistry (708 papers) and Oncology (498 papers) specifically the topics of Computational Drug Discovery Methods (248 papers), Receptor Mechanisms and Signaling (230 papers) and Chemical Synthesis and Analysis (206 papers). The most active scholars publishing in ACS Medicinal Chemistry Letters are Claudiu T. Supuran, Nathanael S. Gray, Ke Ding, Brian S. J. Blagg and Peter Wipf.

In The Last Decade

Fields of papers published in ACS Medicinal Chemistry Letters

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in ACS Medicinal Chemistry Letters. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in ACS Medicinal Chemistry Letters

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in ACS Medicinal Chemistry Letters. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in ACS Medicinal Chemistry Letters with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025